Unknown

Dataset Information

Reduced mortality and severe disability rates in the SENTIS trial.


ABSTRACT:

Background and purpose

The Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke trial showed a trend for reduced all-cause mortality and positive secondary safety end point outcomes. We present further analyses of the mortality and severe disability data from the Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke trial.

Materials and methods

The Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke trial was a multicenter, randomized, controlled trial that evaluated the safety and effectiveness of the NeuroFlo catheter in patients with stroke. The current analysis was performed on the as-treated population. All-cause and stroke-related mortality rates at 90 days were compared between groups, and logistic regression models were fit to obtain ORs an

SUBMITTER: Schellinger PD 

PROVIDER: S-EPMC4156593 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature